April 7, 2026

FTC Announcement of Healthcare Task Force Coincides with Joint DOJ/FTC Appearance at ONC Annual Meeting

LinkedIn Facebook X Send Embed

Two recent developments suggest that enforcers are poised to grapple with antitrust concerns in health tech, signaling an escalation of scrutiny into Information Blocking 1 tactics that have persisted despite U.S. Department of Health and Human Services (HHS) rules and regulations designed to curtail such practices. Stakeholders and industry participants should be prepared for potential outreach.

ONC Annual Meeting

First, on February 12, 2026, the Office of the National Coordinator for Health Information Technology (ONC) held its annual meeting in Washington, D.C. During this event, ONC and Office of Inspector General (OIG) representatives were joined by (previously unannounced) representatives from the U.S. Department of Justice Antitrust Division (DOJ) and the Federal Trade Commission (FTC). During this session, the DOJ and FTC attorneys invoked many hallmarks of antitrust enforcement: the procompetitive aspects of the Information Blocking regulations, switching costs/lock-in, the importance of data interoperability and portability, and intolerance for pretextual arguments predicated on unverifiable concerns over patient safety. The DOJ and FTC emphasized that these concerns are more pronounced in circumstances where a single actor exercises undue market influence.

FTC Announces Healthcare Task Force

Just about a month later, on March 20, 2026, FTC Chairman Andrew Ferguson issued a Directive Regarding Healthcare Task Force applicable across the entire FTC (i.e., Bureau of Competition, Bureau of Consumer Protection, Bureau of Economics, Office of Policy Planning, and the Chief Technology Officer). 2 The Directive establishes a Healthcare Task Force, comprised of all the functions identified above, that will “share knowledge, resources, third-party sources, market intelligence, case leads, and relationships with other agencies and stakeholders.” In other words, the FTC has announced its intention to serve as the coordinator and clearinghouse for antitrust enforcement in healthcare with the purpose of “taking a coherent approach to addressing consumer-protection and competition problems in the healthcare industry.”

The Directive also emphasizes the FTC’s “dual mandate” to protect Americans from both “unfair or deceptive practices and unfair methods of competition.”

The announcement specifically mentions coordination with the HHS and the DOJ, and included several specific goals for the Task Force:

• identify and lead targeted enforcement and advocacy initiatives focused on key priorities;
• devise coherent agency-wide strategies on new and nascent investigations;
• institute a proactive and strategic approach to identifying amicus and statement of interest opportunities; and
• conduct ongoing horizon-scanning exercises to identify emerging issues and new priority areas for enforcement and advocacy. Implications

The combination of the joint DOJ-FTC appearance at the ONC annual meeting followed by the FTC’s announcement of the Healthcare Task Force portend a wave of enforcement. Moreover, this enforcement could take any, or several, different forms, all stemming from an array of mandates and investigative tools available to the relevant agencies. The Healthcare Task Force purports to consolidate information, meaning that any company active in this space will need to be cognizant of the different mandates and prerogatives connected to any information request.

[1] Information Blocking refers to the practice of interfering with the access, exchange or use of Electronic Health Information (EHI), and is subject to the Health Data, Technology, and Interoperability (HTI) Rules issued by the Office of the National Coordinator for Health Information Technology (ONC) pursuant to the 21st Century Cures Act.

[2] https://www.ftc.gov/system/files/ftc_gov/pdf/Memorandum-Ferguson-re-Healthcare-Task-Force.pdf.

Send Print Report

Related Posts

• CFTC Turns Up the Spotlight on Prediction Markets
• FTC Promotes Age Verification in Children’s Privacy Enforcement Statement
• Federal Court Vacates FTC’s 2024 HSR Form Rule; Order Stayed Seven Days Pending Appeal

Latest Posts

• FTC Announcement of Healthcare Task Force Coincides with Joint DOJ/FTC Appearance at ONC Annual Meeting
• New SEC Staff Guidance Brings Welcome Certainty to ATM Offerings See more »

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.

©
Wilson Sonsini Goodrich & Rosati
2026

Written by:

Wilson Sonsini Goodrich & Rosati Contact + Follow Brendan Coffman + Follow Jodi Daniel + Follow Jordanne M. Steiner + Follow

PUBLISH YOUR CONTENT ON JD SUPRA

• ✔ Increased readership
• ✔ Actionable analytics
• ✔ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra

Start Publishing »

Published In:

Antitrust Investigations + Follow Data-Sharing + Follow Department of Health and Human Services (HHS) + Follow Department of Justice (DOJ) + Follow Digital Health + Follow Enforcement Actions + Follow Federal Trade Commission (FTC) + Follow Healthcare + Follow Information Blocking Rules + Follow Regulatory Oversight + Follow Antitrust & Trade Regulation + Follow Health + Follow Science, Computers & Technology + Follow more

Wilson Sonsini Goodrich & Rosati on:

Solve with 2Captcha

Solve with 2Captcha